Commonwealth Equity Services’s 10x Genomics TXG Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $158K | Buy |
+13,673
| New | +$158K | ﹤0.01% | 3980 |
|
|
2025
Q1 | – | Sell |
-10,137
| Closed | -$146K | – | 4288 |
|
|
2024
Q4 | $146K | Buy |
+10,137
| New | +$146K | ﹤0.01% | 3836 |
|
|
2024
Q2 | – | Sell |
-5,526
| Closed | -$207K | – | 4173 |
|
|
2024
Q1 | $207K | Sell |
5,526
-30
| -0.5% | -$1.12K | ﹤0.01% | 3598 |
|
|
2023
Q4 | $311K | Sell |
5,556
-1,637
| -23% | -$91.6K | ﹤0.01% | 3139 |
|
|
2023
Q3 | $297K | Buy |
7,193
+1,486
| +26% | +$61.4K | ﹤0.01% | 3042 |
|
|
2023
Q2 | $319K | Sell |
5,707
-323
| -5% | -$18.1K | ﹤0.01% | 2998 |
|
|
2023
Q1 | $336 | Sell |
6,030
-1,498
| -20% | -$83 | ﹤0.01% | 2864 |
|
|
2022
Q4 | $274K | Sell |
7,528
-30
| -0.4% | -$1.09K | ﹤0.01% | 2944 |
|
|
2022
Q3 | $215K | Sell |
7,558
-24
| -0.3% | -$683 | ﹤0.01% | 3107 |
|
|
2022
Q2 | $343K | Sell |
7,582
-1,684
| -18% | -$76.2K | ﹤0.01% | 2720 |
|
|
2022
Q1 | $704K | Sell |
9,266
-147
| -2% | -$11.2K | ﹤0.01% | 2258 |
|
|
2021
Q4 | $1.4M | Buy |
9,413
+47
| +0.5% | +$7K | ﹤0.01% | 1742 |
|
|
2021
Q3 | $1.36M | Sell |
9,366
-1,626
| -15% | -$237K | ﹤0.01% | 1704 |
|
|
2021
Q2 | $2.15M | Sell |
10,992
-7
| -0.1% | -$1.37K | 0.01% | 1376 |
|
|
2021
Q1 | $1.99M | Buy |
10,999
+693
| +7% | +$125K | 0.01% | 1327 |
|
|
2020
Q4 | $1.46M | Buy |
10,306
+240
| +2% | +$34K | ﹤0.01% | 1414 |
|
|
2020
Q3 | $1.26M | Buy |
+10,066
| New | +$1.26M | ﹤0.01% | 1362 |
|